Zobrazeno 1 - 4
of 4
pro vyhledávání: '"Rocio González-Grande"'
Autor:
Manuel Rodríguez-Perálvarez, Gonzalo Crespo, Jesús Rivera, Antonio González Rodríguez, Estefanía Berge Garrido, Mikel Gastaca, Patricia Ruiz, Anna Curell, Cristina Dopazo, Ainhoa Fernández-Yunquera, Fernando Diaz, Ana Sánchez Martínez, María Luisa Ortiz, Marina Berenguer, Tommaso Di Maira, Jose Ignacio Herrero, Mercedes Iñarrairaegui, Carolina Almohalla, Esteban Fuentes Valenzuela, Sara Lorente Perez, Cristina Borao, Fernando Casafont, Emilio Fabrega, Sonia Pascual, Patricio Más-Serrano, Maria Angeles Lopez Garrido, Flor Nogueras López, Rocio González-Grande, Javier Zamora, Rafael Alejandre, Antonio M. Gómez-Orellana, Carmen Bernal, Miguel Ángel Gómez Bravo
Publikováno v:
Journal of Hepatology. 77:S114
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::caaeee4f9db11a3d96c6e3f134074a4f
https://doi.org/10.1016/s0168-8278(22)00614-6
https://doi.org/10.1016/s0168-8278(22)00614-6
Autor:
Alejandro Cueto-Sanchez, Judith Sanabria Cabrera, Mercedes Robles-Diaz, Aida Ortega-Alonso, Miren Garcia Cortes, Enrique del Campo-Herrera, Rocio Gonzalez-Grande, Miguel Jimenez-Perez, Francisco Ruiz-Cabello, M Isabel Lucena, Camilla Stephens, Raúl J Andrade
Publikováno v:
Annals of Hepatology, Vol 24, Iss , Pp 100489- (2021)
Introduction: Idiosyncratic DILI is a challenging condition, believed to involve the immune system. This hypothesis is supported by various identified HLA risk alleles. Objectives: To evaluate a potential role of the immune system in DILI through leu
Externí odkaz:
https://doaj.org/article/939b0fcda1804da28889a44a9b58db2d
Publikováno v:
Revista Espanola de Enfermedades Digestivas, Vol 109, Iss 9, Pp 659-662
Vedolizumab is a humanized IgG1 monoclonal antibody that selectively blocks the lymphocyte integrin α4β7 and prevents its interaction with endothelial adhesion molecules and subsequent transmigration to the gastrointestinal tract. The drug was appr
Externí odkaz:
https://doaj.org/article/8f7ef53c75a34ac8bf84efe86c40bed7
Publikováno v:
Revista Espanola de Enfermedades Digestivas, Vol 109, Iss 8, Pp 559-565
Background and objective: Oral tacrolimus is an effective drug that induces clinical remission in patients with moderate to severe ulcerative colitis refractory to steroids. However, there is little data with regard to its medium to long-term efficac
Externí odkaz:
https://doaj.org/article/ffe1a15ebc164f4fbe88ba7ec23d187e